Skip to content
Buy This GLP
← Research
Evidence

Can a GLP-1 Cause Malnutrition? What the Studies Measured

Reduced appetite can make it harder to eat enough. Tirzepatide trials and a small surgery study measured different signs of nutritional risk.

Editorial profile: Neil SandersBuy This GLP Editorial Team4 min read
Low lymphocyte counts in SURMOUNT trialsTirzepatide91 of 3,141 (2.90%)Placebo28 of 1,585 (1.77%)A low count alone cannot diagnose malnutrition.

GLP-1 medicines can reduce appetite enough to make it harder to get enough energy or nutrients. The available studies use different measures, so they cannot give one reliable rate of clinically diagnosed malnutrition across these medicines[1] [3].

What the tirzepatide trials recorded

A case report of ketoacidosis after tirzepatide describes one patient. It cannot establish how often that complication occurs or whether tirzepatide caused it.

Our guide to protein intake on a GLP-1 explains how smaller portions can reduce the grams of protein you eat. In a separate analysis of four SURMOUNT trials, researchers looked for adverse-event reports that could indicate poor nutrition. Reports of abnormal weight loss, underweight and low albumin were uncommon. The trials did not routinely measure vitamin and mineral levels [1].

After randomization, the low lymphocyte count rate was 2.90% with tirzepatide compared with 1.77% with placebo (91 of 3,141 and 28 of 1,585 people, respectively). The analysis excluded existing low counts from the event totals. The pooled placebo group included participants who switched to placebo after a tirzepatide run-in in SURMOUNT-4 [1].

What a joint replacement study found

A single center reviewed preoperative lab results for 165 people undergoing elective hip or knee replacement. At least one nutrition-related lab value was abnormal in 11 of 29 GLP-1 users (38%) and 12 of 136 nonusers (8.8%). At least two values were abnormal in 5 of 29 and 4 of 136, respectively. The researchers used their own lab-based definition and the study cannot establish that GLP-1 use caused the findings [2].

Our guide to GLP-1 medicines before surgery covers medication planning for procedures. If you are preparing for surgery, tell the team if low appetite, nausea or vomiting has made it hard to eat or drink normally [3].

When nutrition support may help

A multisociety advisory emphasizes assessing food intake and physical function, managing gastrointestinal side effects, and tailoring nutrition support to the individual. A clinician or registered dietitian can help assess persistent low intake or unintended weight loss [3].

Frequently asked

Can a GLP-1 cause malnutrition?
GLP-1 medicines can reduce appetite enough to make it harder to get adequate nutrition. Available studies do not establish a single rate of clinically diagnosed malnutrition.
Can a low lymphocyte count diagnose malnutrition?
A low lymphocyte count alone cannot diagnose malnutrition. Clinicians assess physical signs, food intake, and health conditions that can affect nutrition.
What should I do if I am consistently eating very little?
Contact your prescriber if you are struggling to eat enough or keep food down. Your clinician or a registered dietitian can assess your intake and help you plan next steps.

Sources

  1. [1] Almandoz JP, Pickett-Blakely O, Tewksbury C, et al. (2026). Nutritional status with tirzepatide in obesity: A post hoc analysis of the SURMOUNT-1–4 randomized clinical trials Obesity Pillars. PMID 41640675
  2. [2] Jodoin Z, Young WH, Sheikh D, et al. (2025). Malnutrition is Common in Patients Utilizing Glucagon-Like Peptide-1 Agonists Prior to Total Joint Arthroplasty Arthroplasty Today. PMID 41079677
  3. [3] Mozaffarian D, et al. (2025). Nutritional priorities to support GLP-1 therapy for obesity: a joint advisory Obesity. Source
  4. [4] Jensen GL, Cederholm T, Correia MITD, et al. (2025). GLIM consensus approach to diagnosis of malnutrition: A 5-year update Journal of Parenteral and Enteral Nutrition. Source

Where to get it

Price the injectable sellers

The desk lists every seller that publishes an injectable figure, with the advertised price struck against the one a buyer is billed.

Open the price desk →

More in Evidence